ArchPoint Investors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-168,725
| Closed | -$11.5M | – | 65 |
|
|
2022
Q3 | $11.5M | Sell |
168,725
-5,040
| -3% | -$343K | 4.69% | 5 |
|
|
2022
Q2 | $5.55M | Sell |
173,765
-4,024
| -2% | -$129K | 2.2% | 14 |
|
|
2022
Q1 | $6.16M | Sell |
177,789
-16,000
| -8% | -$554K | 2.12% | 13 |
|
|
2021
Q4 | $5.67M | Sell |
193,789
-3,000
| -2% | -$87.8K | 1.68% | 19 |
|
|
2021
Q3 | $5.01M | Buy |
196,789
+8,281
| +4% | +$211K | 1.5% | 16 |
|
|
2021
Q2 | $6.6M | Sell |
188,508
-10,142
| -5% | -$355K | 2.24% | 10 |
|
|
2021
Q1 | $8.1M | Sell |
198,650
-18,860
| -9% | -$769K | 2.29% | 8 |
|
|
2020
Q4 | $9.42M | Hold |
217,510
| – | – | 2.61% | 6 |
|
|
2020
Q3 | $12M | Buy |
217,510
+27,130
| +14% | +$1.5M | 3.83% | 5 |
|
|
2020
Q2 | $12M | Buy |
190,380
+1,274
| +0.7% | +$80.4K | 3.85% | 4 |
|
|
2020
Q1 | $9.66M | Buy |
189,106
+2,350
| +1% | +$120K | 3.81% | 5 |
|
|
2019
Q4 | $14.8M | Buy |
186,756
+30,521
| +20% | +$2.43M | 4.54% | 4 |
|
|
2019
Q3 | $7.58M | Sell |
156,235
-400
| -0.3% | -$19.4K | 2.56% | 7 |
|
|
2019
Q2 | $8.24M | Buy |
156,635
+14,950
| +11% | +$786K | 2.61% | 7 |
|
|
2019
Q1 | $7.5M | Buy |
141,685
+2,000
| +1% | +$106K | 2.24% | 7 |
|
|
2018
Q4 | $5.73M | Buy |
139,685
+10,250
| +8% | +$421K | 1.99% | 7 |
|
|
2018
Q3 | $4.92M | Buy |
129,435
+40,595
| +46% | +$1.54M | 1.34% | 16 |
|
|
2018
Q2 | $4.02M | Buy |
88,840
+82,840
| +1,381% | +$3.74M | 1.16% | 18 |
|
|
2018
Q1 | $290K | Buy |
6,000
+3,500
| +140% | +$169K | 0.09% | 85 |
|
|
2017
Q4 | $98K | Buy |
+2,500
| New | +$98K | 0.03% | 100 |
|